You are here: All Products  > AstraZeneca's Tagrisso Approved in China Following Priority Review

AstraZeneca's Tagrisso Approved in China Following Priority Review

Price: $5.00
Available
Get instant access to this article for unlimited viewing and/or downloading for seven days.

Back to products